Morphological Change in Pseudomonas aeruginosafollowing Antibiotic Treatment of Experimental Infection in Mice and Its Relation to Susceptibility to Phagocytosis and to Release of Endotoxin
暂无分享,去创建一个
N. Koide | Tomoaki Yoshida | T. Yokochi | A. Morikawa | T. Sugiyama | M. Kawai | Y. Kato | M. Fukada | Kazuko Takahashi | Kayou Narita | T. Yoshida
[1] N. Koide,et al. Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem , 1997, Antimicrobial agents and chemotherapy.
[2] N. Koide,et al. Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide , 1996, Antimicrobial agents and chemotherapy.
[3] J. Prins. Antibiotic induced release of endotoxin - clinical data and human studies , 1996 .
[4] S. Deventer,et al. Clinical relevance of antibiotic-induced endotoxin release , 1994, Antimicrobial Agents and Chemotherapy.
[5] R. Eng,et al. Effect of antibiotics on endotoxin release from gram-negative bacteria. , 1993, Diagnostic microbiology and infectious disease.
[6] J. Hurley,et al. Antibiotic-induced release of endotoxin: a reappraisal. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] J. Jackson,et al. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. , 1992, The Journal of infectious diseases.
[8] E. Faist. Differential release and impact of antibiotic-induced endotoxin , 1995 .